The company, formerly known as InPress Technologies, produces a medical device that uses vacuum-induced tamponade to address the most common underlying cause of PPH, resulting in normal postpartum uterine contractions over time. This reduces healthcare costs and the risk of maternal mortality associated with PPH. Recently acquired by Organon, Alydia Health is dedicated to improving the lives of women worldwide.